Tag : Type 2 / drug therapy*

Cardiology

Changes in the Prescription of Glucose-Lowering Medications in Patients With Type 2 Diabetes Mellitus After a Cardiovascular Event: A Call to Action From the DATAFILE Study.

Newsemia
Related Articles Changes in the Prescription of Glucose-Lowering Medications in Patients With Type 2 Diabetes Mellitus After a Cardiovascular Event: A Call to Action From...
Pharma / Biotech

Oral Semaglutide: A Review of the First Oral Glucagon-Like Peptide 1 Receptor Agonist.

Newsemia
Related Articles Oral Semaglutide: A Review of the First Oral Glucagon-Like Peptide 1 Receptor Agonist. Diabetes Technol Ther. 2020 01;22(1):10-18 Authors: Bucheit JD, Pamulapati LG,...
Pharma / Biotech

Oral delivery of exenatide-loaded hybrid zein nanoparticles for stable blood glucose control and β-cell repair of type 2 diabetes mice.

Newsemia
Related Articles Oral delivery of exenatide-loaded hybrid zein nanoparticles for stable blood glucose control and β-cell repair of type 2 diabetes mice. J Nanobiotechnology. 2020...
Cardiology

Does Metformin Interfere With the Cardiovascular Benefits of SGLT2 Inhibitors? Questions About Its Role as the Cornerstone of Diabetes Treatment.

Newsemia
Related Articles Does Metformin Interfere With the Cardiovascular Benefits of SGLT2 Inhibitors? Questions About Its Role as the Cornerstone of Diabetes Treatment. Am J Med....
Cardiology

Incremental risk of cardiovascular disease and/or chronic kidney disease for future ASCVD and mortality in patients with type 2 diabetes mellitus: ACCORD trial.

Newsemia
Related Articles Incremental risk of cardiovascular disease and/or chronic kidney disease for future ASCVD and mortality in patients with type 2 diabetes mellitus: ACCORD trial....
Cardiology

Largest single-centre experience of dulaglutide for management of diabetes mellitus in solid organ transplant recipients.

Newsemia
Related Articles Largest single-centre experience of dulaglutide for management of diabetes mellitus in solid organ transplant recipients. Diabetes Obes Metab. 2019 04;21(4):1061-1065 Authors: Singh P,...
Cardiology

Efficacy and safety of empagliflozin in older patients in the EMPA-REG OUTCOME® trial.

Newsemia
Related Articles Efficacy and safety of empagliflozin in older patients in the EMPA-REG OUTCOME® trial. Age Ageing. 2019 11 01;48(6):859-866 Authors: Monteiro P, Bergenstal RM,...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy